Department of Preventive Medical Sciences, Fujita Health University School of Medical Sciences, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192, Japan.
Institute for Biomedicine, Eurac Research, Via A.Volta 21, Bolzano/Bozen, 39100, Italy.
Hypertens Res. 2024 Sep;47(9):2284-2294. doi: 10.1038/s41440-024-01766-9. Epub 2024 Jul 3.
Although previous polygenic risk score (PRS) studies for cardiovascular disease (CVD) focused on incidence, few studies addressed CVD mortality and quantified risks by environmental exposures in different genetic liability groups. This prospective study aimed to examine the associations of blood pressure PRS with all-cause and CVD mortality and to quantify the attributable risk by modifiable lifestyles across different PRS strata. 9,296 participants in the Japan Multi-Institutional Collaborative Cohort Study without hypertension at baseline were analyzed in this analysis. PRS for systolic blood pressure and diastolic blood pressure (PRS and PRS) were developed using publicly available Biobank Japan GWAS summary statistics. CVD-related mortality was defined by the International Classification of Diseases 10th version (I00-I99). Cox-proportional hazard model was used to examine associations of PRSs and lifestyle variables (smoking, drinking, and dietary sodium intake) with mortality. During a median 12.6-year follow-up period, we observed 273 all-cause and 41 CVD mortality cases. Compared to the middle PRS group (20-80th percentile), adjusted hazard ratios for CVD mortality at the top PRS group ( > 90th percentile) were 3.67 for PRS and 2.92 for PRS. Attributable risks of CVD mortality by modifiable lifestyles were higher in the high PRS group ( > 80th percentile) compared with the low PRS group (0-80th percentile). In summary, blood pressure PRS is associated with CVD mortality in the general Japanese population. Our study implies that integrating PRS with lifestyle could contribute to identify target populations for lifestyle intervention even though improvement of discriminatory ability by PRS alone is limited.
虽然之前针对心血管疾病(CVD)的多基因风险评分(PRS)研究主要集中在发病率上,但很少有研究针对 CVD 死亡率,并量化了不同遗传易感性组中环境暴露的风险。本前瞻性研究旨在探讨血压 PRS 与全因和 CVD 死亡率的相关性,并量化不同 PRS 分层中可改变生活方式的归因风险。本分析纳入了基线时无高血压的日本多机构合作队列研究的 9296 名参与者。使用公开的日本生物银行 GWAS 汇总统计数据,开发了收缩压和舒张压的 PRS(PRS 和 PRS)。CVD 相关死亡率由国际疾病分类第 10 版(I00-I99)定义。Cox 比例风险模型用于检验 PRS 和生活方式变量(吸烟、饮酒和饮食钠摄入量)与死亡率的相关性。在中位数为 12.6 年的随访期间,我们观察到 273 例全因死亡和 41 例 CVD 死亡。与中间 PRS 组(20-80 百分位)相比,PRS 组( > 90 百分位)和 PRS 组的 CVD 死亡率校正后的风险比分别为 3.67 和 2.92。与低 PRS 组(0-80 百分位)相比,高 PRS 组( > 80 百分位)中可改变生活方式的 CVD 死亡率归因风险更高。总之,血压 PRS 与日本普通人群的 CVD 死亡率相关。我们的研究表明,即使 PRS 单独改善判别能力有限,将 PRS 与生活方式相结合也可以帮助确定生活方式干预的目标人群。